Figure 4.
Molecular structure of representative compounds targeting early and late stages of HCV life cycle. A. Identified inhibitors targeting the entry stage of HCV infection; B. Identified inhibitors targeting the trafficking stage of HCV infection; C. Identified inhibitors targeting the assembly/secretion stage of HCV infection.